|
HEALTH CARE INNOVATION PUBLICATIONS
“How
Physicians Can Change the Future of Health Care.”
Journal of the American Medical Association, JAMA.
2007;297:1103-1111, March 14, 2007. Co-authored with Michael
E. Porter.
“Driving Improvement in Value for Patients.” Online
Exclusive, The Cerner Quarterly, vol. 2, no.
3, 2006. http://www.cerner.com/public/CernerQuarterly.asp?id=27750.
Interview: “Michael Porter and Elizabeth Teisberg on
Redefining Value in Health Care: An Interview.” Interviewed
by Alistair Davidson and Robert M. Randall, Strategy
and Leadership, vol. 34, no.6, 2006, pp. 48-50.
“Doctor Know: Information Is The Best Medicine.” The
New Republic, July 2006. Co-authored with Michael
Porter.
Redefining Health Care: Creating Value Based
Competition on Results. Harvard Business School
Press. May 2006. Co-authored with Michael E. Porter.
“Redefining Competition in Health Care.” Harvard
Business Review, June 2004, pp. 64-77.
Co-authored with Michael E. Porter.
“Fixing Competition in U.S. Health Care.” HBR Research
Report, June 2004, Product number 7081. Co-authored
with Michael E. Porter.
A Script - Innovation Is the Key. EIU Healthcare
International, Economist Intelligence Unit Limited,
1st Quarter 1997, pp. 79-88. Co-authored with Gregory B.
Brown.
“Building on Strength: Upgrading the Medical Device Cluster
in Massachusetts.” Governor’s Council on Economic Growth and
Technology, prepared for Governor Weld of
Massachusetts with the assistance of Yiannis
Monovoukas and Scott Wilkin, March 1995. (This work with
about 15 CEOs led to the formation of Mass Medical, the
state’s medical device industry association.)
“Making Competition in Health Care Work.” Harvard
Business Review, July-August 1994, vol. 72, no. 4,
pp. 131-141. Co-authored with Michael E. Porter and Gregory
B. Brown.
“The Role of Biomedical Research in Health Care Reform.”
Science, October 7, 1994. Co-authored with M.W.
Kirschner and Elizabeth Marincola.
“Innovation: Medicine's Best Cost-Cutter.” Viewpoints
column. The New York Times, February 27, 1994.
Co-authored with Michael E. Porter and Gregory B. Brown.
“The Debate on Health Care Reform Continues.” Harvard
Business Review, November-December 1994. Co-authored
with Michael E. Porter and Gregory B. Brown.
“Finding a Lasting Cure for U.S. Health Care.” Perspectives
column. Harvard Business Review,
September-October 1994. Co-authored with Michael E. Porter
and Gregory B. Brown.
STRATEGY AND REAL OPTIONS PUBLICATIONS
The Portable MBA, Fourth Edition. John
Wiley & Sons, Inc., New York, 2003. Co-authored with R.F.
Bruner, M.R. Eaker, R.E. Freeman, R.E. Spekman and S.
Venkataraman.
“Sustainable Business: Opportunity and Value Creation.”
INTERFACES, May-June 2000, 30, no. 3, pp. 1-12.
Co-authored with A. Larson and R. Johnson.
Special Issue of INTERFACES on Sustainable Business.
May-June 2000. Co-editor with A. Larson.
“Introduction: Strategy, Modeling and Analysis.”
INTERFACES, November-December 1999, 29, no. 6, pp.
1-3. Co-authored with S. Bodily.
Special Issue of INTERFACES on Strategy, Analysis and
Models. November-December 1999, 29, no. 6. Co-editor
with S. Bodily.
The Portable MBA, Third Edition. John
Wiley & Sons, Inc., New York, 1998. Co-authored with R.F.
Bruner, M.R. Eaker, R.E. Freeman, and R.E. Spekman.
Translated into Japanese (1998), Portuguese (1999), Chinese
(1999) and Russian (2000).
“Methods for Evaluating Capital Investment Decisions Under
Uncertainty.” Real Options in Capital Investment:
New Contributions. Edited by Lenos Trigeorgis.
Westport, CT: Praeger Publishing, 1995.
“An Option Valuation Analysis of Investment Choices by a
Regulated Firm.” Management Science, April
1994, vol. 40, no. 4, pp. 535-548.
“Capital Investment Strategies Under Uncertain Regulation.”
The RAND Journal of Economics, Winter 1993,
vol. 24, no. 4, pp. 591-604.
“The Value of Commodity Purchase contracts with Limited
Price Risk.” The Energy Journal, 1991, vol.
12, no. 3, pp. 109-135. Co-authored with Thomas J. Teisberg.
“When Choosing R&D Projects, Go with Long Shots.”
Research-Technology Management, January-February
1991. Co-authored with A.L. Kolbe and P.A. Morris.
“Investment Cost Recovery and Incentives for Power Plant
Construction.” Public Utilities Fortnightly,
March 3, 1988, vol. 121, no. 5, pp. 9-14.
“Evaluating the Effects of Time and Risk on Investment
Choices: A Comparison of Finance and Decision Analysis.”
Electric Power Research Institute Project,
2379-4, January 1987. Co-authored with A.L. Kolbe and P.A.
Morris.
OTHER PUBLICATIONS
“Managing Ideas.” Autumn 2003. Batten Briefings.
Co-authored with C. Thompson and K. Ramdas.
“Analyzing R&D and Policy Options for the Greenhouse
Effect.” The Energy Industries in Transition:
1985-2000, Part I. Edited by J.P. Weyant and D.B.
Sheffield, International Association of Energy Economists,
1984. Co-authored with B.R. Judd and L.J. Pollenz.
COURSE DEVELOPMENT MATERIALS
INNOVATION (INCLUDING HEALTH SECTOR INNOVATION)
Sarcos Research Corp 2004, UVA-S-0119
Sarcos Research Corp (TN) 2004, UVA-S-0119TN
Barraquer Clinic 2004, (Columbian eye surgery clinic)
Managing Health Benefits: The Dilemma of Joining the
Leapfrog Group (A)
2004, UVA-S-0113
Managing Health Benefits: The Dilemma of Joining the
Leapfrog Group (B)
2004, UVA-S-0114
Magnetic Surgery System (A)
December 1999, UVA-OM-0888
Magnetic Surgery System: B, C, D and E
December 1999, UVA-OM-0889, 0890, 0891 and 0892
Managing Innovation at GE Medical Systems (A)
December 1998, UVA-OM-0882
Managing Innovation at GE Medical Systems (B)
1999, UVA-OM-0883
Option Valuation: Insights and Explanations Using a Binomial
Approach
July 1999, UVA-OM-0900
Seaflower Associates, Inc.: Valuing Venture Capital with
Real Options
January, 1999, UVA-OM-0884
Active Coatings, Inc. (A) - Challenges in Managing Product
Development
February 1996, Harvard Business School, no. 9-796-061
Active Coatings, Inc. (B) - Challenges in Managing Product
Development
February 1996, Harvard Business School, no. 9-796-062
Note on the FDA Approval Process for Medical Devices
November 1995, Harvard Business School, no. 9-796-063
Zoll Medical Corporation
December 1994, Harvard Business School, no. 9-795-053
Zoll Medical Corporation: B and C
December 1994, Harvard Business School, no. 9-795-054 and
no. 9-795-055
Alpha-Beta Technology, Inc., Pioneering Carbohydrate
Technology
February, 1994, Harvard Business School, no. 9-794-093
Alpha-Beta Technology, Inc. (B): Trials with Betafectin
December, 1994, Harvard Business School, no. 9-795-045
Diagnosis for the Future: The Genetic Testing Industry in
1993
February 1994, Harvard Business School, no. 9-794-053
IG Laboratories Inc. (A): Pursuing the Future of Genetic
Testing
October 1994, Harvard Business School, no. 9-794-054
IG Laboratories, Inc. (B): The Paradox of Growth – 1993-94
February 1996, Harvard Business School, no. 9-796-114
Genzyme Corporation
April 1993, Rev. May 1994, Harvard Business School,
no.9-793-120 and TN no. 5-793-122
Biotechnology Strategies in 1992
April 1992, Rev. June 1993, Harvard Business School,
no.9-792-082 and TN no. 5-793-036
|